DPT and Confab Complete $10 Million Capital Investment in San Antonio and Montreal

DPT and Confab Complete $10 Million Capital Investment in San Antonio and Montreal

(San Antonio, March 8, 2016) — DPT Laboratories, a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms, and Confab, a DPT company specializing in complex solids, semi-solids and liquids, have completed a combined $10 million capital investment demonstrating their commitment to continuous improvement.

San Antonio-based DPT has invested in a new compounding suite and significant upgrades to production filling lines that will increase capacity, throughput and precision. Additional upgrades include a remodeled front office area and enhanced security to further restrict access to the manufacturing floor and further enhance GMP compliance.

Confab, based in Montreal, made a significant investment to increase R&D capabilities with a new state-of-the-art laboratory, new equipment and expansion of its R&D team. Confab can now offer customers pharmaceutical development capabilities ranging from formulation development and analytical method development to technology transfers at commercial scale.

"The investments in capital demonstrate our continuing commitment to provide high-quality development and manufacturing solutions to our partners," said Paul Josephs, senior vice president of sales, marketing and corporate development. "We are excited about the strong demand for our services and look forward to discussing our enhanced capabilities with our customers during DCAT week."

DPT and Confab will be available to discuss their expanded facilities and services during DCAT Week, March 14-17 in New York City. For more information on DPT and Confab capabilities, visit DPTConfab.com.

About DPT
DPT is a contract development and manufacturing organization (CDMO) helping pharmaceutical companies achieve clinical and commercial success. With cGMP-compliant facilities in San Antonio, Texas, DPT applies a Quality by Design (QbD) methodology to investigate your product and discover and deliver the optimal solutions from development through commercialization. We bring vast experience in resolving development and manufacturing challenges in semi-solids and liquids. From drug pre-formulation and formulation, to analytical method development and technology transfers, to production and distribution, DPT is your partner all the way through full-scale worldwide commercialization — visit DPTLabs.com.

About Confab
Confab, a DPT company, is a fully integrated contract development and manufacturing organization (CDMO) specializing in complex solid dose, semi-solid and liquid products. Through a thorough examination of your product and a solutions-oriented approach, we help you meet and exceed the pharmaceutical industry's highest standards. Our experience spans more than 30 years and will set the basis for your success, all the way to market. For more information, visit Confab.com.

Read more on